×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ICLR – icon plc - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ICLR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:25 am
iclr
Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR)
Medium
Report
Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR)
11/20
08:06 am
iclr
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Robert W. Baird from $249.00 to $225.00. They now have a "neutral" rating on the stock.
Medium
Report
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Robert W. Baird from $249.00 to $225.00. They now have a "neutral" rating on the stock.
11/20
07:25 am
iclr
Levi & Korsinsky Announces an Investigation on Behalf of ICON Public Limited Company (ICLR) Shareholders Who May Have Been Affected by Fraud
Medium
Report
Levi & Korsinsky Announces an Investigation on Behalf of ICON Public Limited Company (ICLR) Shareholders Who May Have Been Affected by Fraud
11/19
10:36 am
iclr
ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $255.00 price target on the stock, down previously from $270.00.
Low
Report
ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $255.00 price target on the stock, down previously from $270.00.
11/19
07:30 am
iclr
Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR)
Medium
Report
Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR)
11/18
09:13 am
iclr
Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech Giants - ArisEurope, ICON plc and Syneos Health | The Insight Partners [Yahoo! Finance]
Low
Report
Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech Giants - ArisEurope, ICON plc and Syneos Health | The Insight Partners [Yahoo! Finance]
11/18
07:30 am
iclr
Shareholder Rights Advocates at Levi & Korsinsky Investigate ICON Public Limited Company (ICLR) Regarding Possible Securities Fraud Violations
Low
Report
Shareholder Rights Advocates at Levi & Korsinsky Investigate ICON Public Limited Company (ICLR) Regarding Possible Securities Fraud Violations
11/15
04:00 pm
iclr
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Low
Report
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Date
Time
Symbol
Company Name
Action
%Chg
10/23/2024
04:15 pm
iclr
icon plc - ordinary shares
MISS
Report
-23.4%
icon plc - ordinary shares
7/24/2024
04:15 pm
iclr
icon plc - ordinary shares
BEAT
Report
-2.7%
icon plc - ordinary shares
4/24/2024
04:15 pm
iclr
icon plc - ordinary shares
MISS
Report
-3.0%
icon plc - ordinary shares
4/24/2024
04:15 pm
iclr
icon plc - ordinary shares
BEAT
Report
-3.0%
icon plc - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
08:06 am
iclr
Form 6-K ICON PLC For: Nov 13
Medium
Report
Form 6-K ICON PLC For: Nov 13
11/12
11:54 am
iclr
Form SC 13G/A ICON PLC Filed by: MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Low
Report
Form SC 13G/A ICON PLC Filed by: MASSACHUSETTS FINANCIAL SERVICES CO /MA/
8/26
04:02 pm
iclr
Form 144 ICON PLC Filed by: Berger Ute Meta
Low
Report
Form 144 ICON PLC Filed by: Berger Ute Meta
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/25
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Mizuho from $160.00 to $170.00. They now have a "buy" rating on the stock.
8.6%
3/26 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, down previously from $182.00. 6.7%
4/29 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 5.9%
10/23 Q3/2019 9/30/2019 EPS 1.740 ZacksConsensus 1.730 ActVsEst 0.010 - Beat 4.5%
12/14 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 2.2%
11/23 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $174.00 price target on the stock. 2.2%
8/8 Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at KeyCorp from $157.00 to $165.00. They now have an "overweight" rating on the stock. 2.2%
6/7 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $159.00 price target on the stock. 1.9%
10/24 ICON Public Limited Company (ICLR) CEO Steve Cutler on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 1.8%
5/16 Form S-8 ICON PLC 1.8%
3/26 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, down previously from $182.00. 6.7%
4/29 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 5.9%
10/23 Q3/2019 9/30/2019 EPS 1.740 ZacksConsensus 1.730 ActVsEst 0.010 - Beat 4.5%
12/14 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 2.2%
11/23 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $174.00 price target on the stock. 2.2%
8/8 Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at KeyCorp from $157.00 to $165.00. They now have an "overweight" rating on the stock. 2.2%
6/7 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $159.00 price target on the stock. 1.9%
10/24 ICON Public Limited Company (ICLR) CEO Steve Cutler on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 1.8%
5/16 Form S-8 ICON PLC 1.8%
TOP News Decliners
4/22
ICON Reports First Quarter 2020 Results
-6.9%
3/2 Icon Plc (NASDAQ: ICLR) is now covered by analysts at Deutsche Bank AG. They set a "hold" rating and a $169.00 price target on the stock. -6.0%
3/18 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -4.2%
3/23 Icon Plc (NASDAQ: ICLR) had its price target lowered by analysts at Jefferies Financial Group Inc from $180.00 to $146.00. They now have a "buy" rating on the stock. -4.0%
10/10 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -3.1%
5/13 ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research -2.9%
2/19 Q4/2019 12/31/2019 EPS 1.830 ZacksConsensus 1.830 ActVsEst 0.000 - In-Line -2.9%
9/7 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -2.2%
1/30 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.0%
5/17 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $155.00 price target on the stock. -2.0%
3/2 Icon Plc (NASDAQ: ICLR) is now covered by analysts at Deutsche Bank AG. They set a "hold" rating and a $169.00 price target on the stock. -6.0%
3/18 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -4.2%
3/23 Icon Plc (NASDAQ: ICLR) had its price target lowered by analysts at Jefferies Financial Group Inc from $180.00 to $146.00. They now have a "buy" rating on the stock. -4.0%
10/10 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -3.1%
5/13 ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research -2.9%
2/19 Q4/2019 12/31/2019 EPS 1.830 ZacksConsensus 1.830 ActVsEst 0.000 - In-Line -2.9%
9/7 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -2.2%
1/30 Icon Plc (NASDAQ: ICLR) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.0%
5/17 Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $155.00 price target on the stock. -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: